Gregory Fusco

891 total citations
57 papers, 614 citations indexed

About

Gregory Fusco is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Gregory Fusco has authored 57 papers receiving a total of 614 indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Infectious Diseases, 34 papers in Virology and 20 papers in Emergency Medicine. Recurrent topics in Gregory Fusco's work include HIV/AIDS drug development and treatment (47 papers), HIV/AIDS Research and Interventions (36 papers) and HIV Research and Treatment (34 papers). Gregory Fusco is often cited by papers focused on HIV/AIDS drug development and treatment (47 papers), HIV/AIDS Research and Interventions (36 papers) and HIV Research and Treatment (34 papers). Gregory Fusco collaborates with scholars based in United States, United Kingdom and Ireland. Gregory Fusco's co-authors include Jennifer S Fusco, Laurence Brunet, Michael Wohlfeiler, Karam Mounzer, Girish Prajapati, A Beyer, Patrick Mallon, Vani Vannappagari, Stephen Becker and Cassidy Henegar and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Hepatology and Journal of Clinical Epidemiology.

In The Last Decade

Gregory Fusco

49 papers receiving 600 citations

Peers

Gregory Fusco

VIROL

EPIDE

Lloyd Curtis United States

Corklin Steinhart United States

María Ángeles Muñoz Spain

María Saumoy Spain

J Gerstoft Denmark

Simone Passerini Italy

Iñaki Pérez Spain

Marc Antoine Valantin France

Stefania Salpietro Italy

Michael Giordano United States

Lloyd Curtis United States

Gregory Fusco

358 ×0.9

285 ×1.1

VIROL

206 ×1.0

79 ×0.7

EPIDE

32 ×0.6

Citations per year, relative to Gregory Fusco Gregory Fusco (= 1×) peers Lloyd Curtis

Countries citing papers authored by Gregory Fusco

Since Specialization

Citations

This map shows the geographic impact of Gregory Fusco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Fusco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Fusco more than expected).

Fields of papers citing papers by Gregory Fusco

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory Fusco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Fusco. The network helps show where Gregory Fusco may publish in the future.

Co-authorship network of co-authors of Gregory Fusco

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory Fusco. A scholar is included among the top collaborators of Gregory Fusco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory Fusco. Gregory Fusco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pierone, Gerald, Jennifer S Fusco, Laurence Brunet, et al.. (2024). Virologically suppressed switch to Dolutegravir/Lamivudine 2-Drug regimen versus switch to commonly prescribed 3-Drug regimens in the United States. AIDS Research and Therapy. 21(1). 76–76. 1 indexed citations

Pierone, Gerald, Jennifer S Fusco, Laurence Brunet, et al.. (2023). 1023. Suppressed Switch to Bictegravir/Emtricitabine/Tenofovir Alafenamide vs. Dolutegravir/Lamivudine: Virologic Failure and Durability. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations

Wohlfeiler, Michael, Rachel Palmieri Weber, Laurence Brunet, et al.. (2023). Definition, Burden, and Predictors of HIV-Associated Wasting and Low Weight in the OPERA Cohort. AIDS Research and Human Retroviruses. 39(12). 636–643.

Mounzer, Karam, Laurence Brunet, Jennifer S Fusco, et al.. (2023). Immune response to ART initiation in advanced HIV infection. HIV Medicine. 24(6). 716–726. 8 indexed citations

Fusco, Jennifer S, Cassidy Henegar, Vani Vannappagari, et al.. (2023). Heavily treatment-experienced people living with HIV in the OPERA® cohort: population characteristics and clinical outcomes. BMC Infectious Diseases. 23(1). 91–91. 5 indexed citations

Sension, Michael, Laurence Brunet, Jennifer S Fusco, et al.. (2023). Cabotegravir + Rilpivirine Long-Acting Injections for HIV Treatment in the US: Real World Data from the OPERA Cohort. Infectious Diseases and Therapy. 12(12). 2807–2817. 30 indexed citations

Sension, Michael, Jennifer S Fusco, Laurence Brunet, et al.. (2023). 1608. Real-World Effectiveness of Long-Acting Cabotegravir + Rilpivirine in Virologically Suppressed Treatment-Experienced Individuals: Two Years of Data from the OPERA® Cohort. Open Forum Infectious Diseases. 10(Supplement_2). 7 indexed citations

Mounzer, Karam, Laurence Brunet, Jennifer S Fusco, et al.. (2022). Advanced HIV Infection in Treatment-Naïve Individuals: Effectiveness and Persistence of Recommended 3-Drug Regimens. Open Forum Infectious Diseases. 9(3). ofac018–ofac018. 23 indexed citations

Brunet, Laurence, et al.. (2022). Excessive Weight Gain: Current Antiretroviral Agents in Virologically Suppressed People with HIV. AIDS Research and Human Retroviruses. 38(10). 782–791. 3 indexed citations

10.

Pierone, Gerald, Jennifer S Fusco, Vani Vannappagari, et al.. (2022). Dolutegravir/rilpivirine 2-drug regimen comparable to commonly prescribed 3-drug regimens up to 18-months in a real-world setting. Antiviral Therapy. 27(1). 2 indexed citations

11.

Mallon, Patrick, Laurence Brunet, Jennifer S Fusco, et al.. (2021). Weight gain before and after switch from TDF to TAF in a U.S. cohort study. Journal of the International AIDS Society. 24(4). e25702–e25702. 95 indexed citations

12.

Brunet, Laurence, Patrick Mallon, Jennifer S Fusco, et al.. (2021). Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living with HIV: Lipid Changes and Statin Underutilization. Clinical Drug Investigation. 41(11). 955–965. 13 indexed citations

13.

Mounzer, Karam, Laurence Brunet, Ricky Hsu, et al.. (2021). Changes in Body Mass Index Associated with Antiretroviral Regimen Switch Among Treatment-Experienced, Virologically Suppressed People Living with HIV in the United States. AIDS Research and Human Retroviruses. 37(11). 852–861. 11 indexed citations

14.

Mills, Anthony, Kathy L. Schulman, Jennifer S Fusco, et al.. (2021). Virologic Outcomes Among People Living With Human Immunodeficiency Virus With High Pretherapy Viral Load Burden Initiating on Common Core Agents. Open Forum Infectious Diseases. 8(8). ofab363–ofab363. 3 indexed citations

15.

Mounzer, Karam, Jennifer S Fusco, Laurence Brunet, et al.. (2021). Are We Hitting the Target? HIV Pre-Exposure Prophylaxis from 2012 to 2020 in the OPERA Cohort. AIDS Patient Care and STDs. 35(11). 419–427. 7 indexed citations

16.

Hsu, Ricky, Laurence Brunet, Jennifer S Fusco, et al.. (2020). Risk of chronic kidney disease in people living with HIV by tenofovir disoproxil fumarate (TDF) use and baseline D:A:D chronic kidney disease risk score. HIV Medicine. 22(5). 325–333. 11 indexed citations

17.

Fusco, Jennifer S, Cassidy Henegar, E. Byrd Quinlivan, et al.. (2019). Integrase Inhibitor-Based Antiretroviral Therapy Among Women Living with HIV: Data from the OPERA Cohort. Current HIV Research. 17(4). 266–276. 1 indexed citations

18.

Mounzer, Karam, Laurence Brunet, Ricky Hsu, et al.. (2019). 978. Changes in BMI Associated with Antiretroviral Regimens in Treatment-Experienced, Virologically Suppressed Individuals Living with HIV. Open Forum Infectious Diseases. 6(Supplement_2). S36–S37. 9 indexed citations

19.

Pierone, Gerald, Cassidy Henegar, Jennifer S Fusco, et al.. (2019). Two‐drug antiretroviral regimens: an assessment of virologic response and durability among treatment‐experienced persons living with HIV in the OPERA^® Observational Database. Journal of the International AIDS Society. 22(12). e25418–e25418. 4 indexed citations

20.

Hsu, Ricky, Jennifer S Fusco, Cassidy Henegar, et al.. (2018). Psychiatric outcomes observed in patients living with HIV using six common core antiretrovirals in the Observational Pharmaco-Epidemiology Research and Analysis database. Therapeutic Advances in Drug Safety. 9(12). 675–686. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact